Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.
A team from the Okinawa Institute of Science and Technology Graduate University has used cryo-EM to model the nucleocapsid protein of Ebola virus, potentially uncovering novel drug targets.
The new species, the Bombali virus, has been identified in bats in Sierra Leone ahead of any human infection.
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
Following a study that shed new light on the psychiatric and neurological problems suffered by Ebola survivors, researchers are calling for more specialist support for this population.
Primarily transferred via direct contact with the blood or bodily fluids of infected people, the Ebola virus receives a significant boost to its infective properties from amyloid fibrils in human semen, according to a new study.
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
Two cases of Ebola have been confirmed in Bikoro in the Democratic Republic of Congo, sparking a response from the government and the WHO.
Researchers have identified that the Ebola virus recruits a host enzyme, PP2A-B56, for replication, demonstrating that inhibiting this pathway could be a target for drug discovery.